Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. (Q24534256)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. |
scientific article |
Statements
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders (English)
Jacques Simiand
Claudine Serradeil-Le Gal
Jean Wagnon
Marc Pascal
Bernard Scatton
Jean-Pierre Maffrand
Philippe Soubrie
16 April 2002
1 reference
1 reference
1 reference
1 reference